Raymond James & Associates’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History
Bought
Maintained
Sold
Other funds holding BSTZ
SCM
RCM
KIM
PCR
PCM
WS
1CP
Raymond James & Associates's BSTZ Position: Q3 2024 in Review
Raymond James & Associates reduced its BlackRock Science and Technology Term Trust (BSTZ) stake by 1.1% in Q3 2024, selling an estimated $201K and leaving 928,967 shares worth $17.8M. The position accounts for 0.01% of the portfolio, ranked #885.
Raymond James & Associates first reported a position in BSTZ in Q2 2019 and has held it in 22 quarters since. The position peaked at $51.6M in Q2 2021. 101 funds tracked by Wall St. Rank hold BSTZ as of Q3 2024.
- Raymond James & Associates held 928,967 shares of BlackRock Science and Technology Term Trust worth $17.8M as of Q3 2024.
- Raymond James & Associates sold 10,539 BlackRock Science and Technology Term Trust shares in Q3 2024, an estimated $201K.
- BlackRock Science and Technology Term Trust made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #885 holding.
- Raymond James & Associates first reported a position in BlackRock Science and Technology Term Trust in Q2 2019 and has held it in 22 quarters since.
- Raymond James & Associates's BlackRock Science and Technology Term Trust position peaked at $51.6M in Q2 2021.
- 101 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.